Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Growing Prevalence Of Hypertension Across The Globe
3.2.2. Surge In Disposable Income And Healthcare Spending
3.2.3. Rising Aging Population
3.3. Key Restraints
3.3.1. Patent Expirations
3.3.2. Delay In Product Launches

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Regulatory Framework
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Drug Class
5.1. Calcium Channel Blockers
5.2. Ace Inhibitors
5.3. Beta-Adrenergic Blockers
5.4. Diuretics
5.5. Vasodilators
5.6. Other Drug Class

6. Market By End-User
6.1. Hospital Pharmacy
6.2. Retail Pharmacy
6.3. E-Commerce Websites & Online Drug Stores

7. Geographical Analysis
7.1. Asia Pacific
7.1.1. China
7.1.2. Japan
7.1.3. India
7.1.4. Australia & New Zealand
7.1.5. South Korea
7.1.6. Thailand
7.1.7. Indonesia
7.1.8. Vietnam
7.1.9. Rest Of Asia Pacific

8. Company Profiles
8.1. Allergan Plc
8.2. Aspire Bariatrics Inc
8.3. Astrazeneca Plc
8.4. Bio-Rad Laboratories Inc
8.5. Boehringer Ingelheim International Gmbh
8.6. Daiichi Sankyo Company Limited
8.7. Hill-Rom Holdings Inc
8.8. Johnson & Johnson
8.9. Lupin Limited
8.10. Medtronic Plc
8.11. Merck & Co Inc
8.12. Novartis Ag
8.13. Pfizer Inc
8.14. Sanofi
8.15. Sun Pharmaceutical Industries Ltd (Ranbaxy Laboratories)



List of Figures


List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Asia Pacific Antihypertensive Drugs Market, By Drug Class, In 2019
Figure 6: Asia Pacific Antihypertensive Drugs Market, By Calcium Channel Blockers, 2019-2028 (In $ Million)
Figure 7: Asia Pacific Antihypertensive Drugs Market, By Ace Inhibitors, 2019-2028 (In $ Million)
Figure 8: Asia Pacific Antihypertensive Drugs Market, By Beta-Adrenergic Blockers, 2019-2028 (In $ Million)
Figure 9: Asia Pacific Antihypertensive Drugs Market, By Diuretics, 2019-2028 (In $ Million)
Figure 10: Asia Pacific Antihypertensive Drugs Market, By Vasodilators, 2019-2028 (In $ Million)
Figure 11: Asia Pacific Antihypertensive Drugs Market, By Other Drug Class, 2019-2028 (In $ Million)
Figure 12: Asia Pacific Antihypertensive Drugs Market, By End-User, In 2019
Figure 13: Asia Pacific Antihypertensive Drugs Market, By Hospital Pharmacy, 2019-2028 (In $ Million)
Figure 14: Asia Pacific Antihypertensive Drugs Market, By Retail Pharmacy, 2019-2028 (In $ Million)
Figure 15: Asia Pacific Antihypertensive Drugs Market, By E-Commerce Websites & Online Drug Stores, 2019-2028 (In $ Million)
Figure 16: Asia Pacific Antihypertensive Drugs Market, Country Outlook, 2019 & 2028 (In %)
Figure 17: China Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 18: Japan Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 19: India Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 20: Australia & New Zealand Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 21: South Korea Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 22: Thailand Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 23: Indonesia Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 24: Vietnam Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 25: Rest Of Asia Pacific Antihypertensive Drugs Market, 2019-2028 (In $ Million)

 

List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - ANTIHYPERTENSIVE DRUGS
TABLE 2: ASIA PACIFIC ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: ASIA PACIFIC ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: ASIA PACIFIC ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: ASIA PACIFIC ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: ASIA PACIFIC ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: ASIA PACIFIC ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)